176 related articles for article (PubMed ID: 36171471)
1. Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma.
Lima HA; Endo Y; Alaimo L; Moazzam Z; Munir MM; Shaikh C; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
J Gastrointest Surg; 2022 Dec; 26(12):2512-2521. PubMed ID: 36171471
[TBL] [Abstract][Full Text] [Related]
2. TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma.
Lima HA; Endo Y; Moazzam Z; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Endo I; Kitago M; Shen F; Pawlik TM
J Surg Oncol; 2023 Mar; 127(3):374-384. PubMed ID: 36194039
[TBL] [Abstract][Full Text] [Related]
3. TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.
Lima HA; Moazzam Z; Endo Y; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
Ann Surg Oncol; 2023 Jun; 30(6):3363-3373. PubMed ID: 36820934
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
[TBL] [Abstract][Full Text] [Related]
5. Prediction of tumor recurrence by α-fetoprotein model after curative resection for hepatocellular carcinoma.
Ding HF; Zhang XF; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Lv Y; Pawlik TM
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):660-666. PubMed ID: 33082065
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
Tsilimigras DI; Moris D; Hyer JM; Bagante F; Sahara K; Moro A; Paredes AZ; Mehta R; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Sasaki K; Rodarte AI; Aucejo FN; Pawlik TM
Br J Surg; 2020 Jun; 107(7):854-864. PubMed ID: 32057105
[TBL] [Abstract][Full Text] [Related]
7. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Farooq A; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Mar; 27(3):866-874. PubMed ID: 31696396
[TBL] [Abstract][Full Text] [Related]
8. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
10. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
11. Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
Tsilimigras DI; Bagante F; Moris D; Merath K; Paredes AZ; Sahara K; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Surgery; 2019 Dec; 166(6):967-974. PubMed ID: 31606196
[TBL] [Abstract][Full Text] [Related]
12. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
[TBL] [Abstract][Full Text] [Related]
13. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma.
Tsilimigras DI; Hyer JM; Diaz A; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670174
[TBL] [Abstract][Full Text] [Related]
16. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
[TBL] [Abstract][Full Text] [Related]
17. Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
Li WF; Yen YH; Liu YW; Wang CC; Yong CC; Lin CC; Cheng YF; Wang JH
Updates Surg; 2022 Aug; 74(4):1345-1352. PubMed ID: 34374920
[TBL] [Abstract][Full Text] [Related]
18. Machine-Based Learning Hierarchical Cluster Analysis: Sex-Based Differences in Prognosis Following Resection of Hepatocellular Carcinoma.
Resende V; Tsilimigras DI; Endo Y; Guglielmi A; Ratti F; Aldrighetti L; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Gleisner A; Martel G; Hugh T; Endo I; Shen F; Pawlik TM
World J Surg; 2023 Dec; 47(12):3319-3327. PubMed ID: 37777670
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
[TBL] [Abstract][Full Text] [Related]
20. Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma.
Lima HA; Alaimo L; Brown ZJ; Endo Y; Moazzam Z; Tsilimigras DI; Shaikh C; Resende V; Guglielmi A; Ratti F; Aldrighetti L; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Shen F; Pawlik TM
HPB (Oxford); 2023 Feb; 25(2):260-268. PubMed ID: 36470717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
